US BANCORP \DE\ - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$13,187
+14.1%
1,446
+32.4%
0.00%
Q2 2023$11,553
+6.7%
1,092
+23.4%
0.00%
Q1 2023$10,824
-46.2%
885
-45.4%
0.00%
Q4 2022$20,117
+0.6%
1,621
+12.3%
0.00%
Q3 2022$20,000
+900.0%
1,444
+977.6%
0.00%
Q2 2022$2,000
-80.0%
134
-78.2%
0.00%
Q1 2022$10,000
-37.5%
614
-27.5%
0.00%
Q3 2021$16,000
+128.6%
847
+182.3%
0.00%
Q2 2021$7,000300
+1775.0%
0.00%
Q1 2021$0
-100.0%
16
-79.2%
0.00%
Q4 2020$3,000770.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders